ILC Research

Pelops trial information with words "completed enrollment"

PELOPS: Clinical Trial with Palbociclib for Pre-surgical ILC Patients

Women who have been diagnosed with Stage 1 – 3 invasive lobular breast cancer (ILC) who have not yet had surgery to remove their tumor may be eligible to participate in a clinical trial.  This trial is open to all ER+ and/or PR+ HER2- patients (ductal or lobular), however it is being enriched with lobular breast cancer patients to promote a better understanding of how ILC might respond differently to these therapies.

PELOPS: Clinical Trial with Palbociclib for Pre-surgical ILC Patients Read More »

Scroll to Top

Join Us

Subscribe for the Latest News & Updates​

  • This field is for validation purposes and should be left unchanged.